{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"","title":"Autism, AI and Epigenetics; Nevan Krogan","description":"

Episode 1 (Week ending December 8, 2023): Nevan Krogan (UCSF) mapping autism pathways; Nvidia’s latest AI partnership; CAR-T regulations; epigenome editing; mRNA therapeutics.

References to the GEN stories, media and other items discussed in this episode of Touching Base:

·        Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction Network

By Julianna Lemieux, GEN, December 5, 2023.


·        Rhapsody in B: Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer

By Jonathan Grinstein, GEN Edge, December 6, 2023.


·        Nvidia Looks to Genentech for its Next Leap in AI Drug Discovery

By Alex Philippidis, GEN Edge, November 28, 2023.


·        StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers

By Alex Philippidis, GEN, December 1, 2023


·        Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning {VIDEO}

GEN Edge, August 30, 2023


·        Press release: John Crowley appointed President & CEO of BIO

Biotechnology Innovation Organization


·        BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”

GEN multimedia, April 26, 2023


·        The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease

GEN, November 16, 2023

","author_name":"Genetic Engineering & Biotechnology News (GEN)"}